tykhr
sign in
free sign up
Entero Therapeutics, Inc.
Biotechnology
Healthcare
ENTO
4.77 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
4.76
52 week high
5.16
high
5.24
52 week low
0.00
low
4.70
growth
149.51 %
previous Close
4.99
P/E ratio
market cap
3.02 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-998.27 K
20.75 %
eps
0.00 %
-141.72 %
eps surprise
0.00 %
net profit margin
-99827100.00 %
0.00 %
operating incoming
-638.86 K
22.22 %
net change in cash
-54.88 K
53.74 %
cash on hand
4.47 K
-92.46 %
cost of revenue
0.00 %
top